Organization
Centre Hospitalier Henri Duffaut
2 clinical trials
3 abstracts
Clinical trial
Effects of Vagus Nerve Osteopathic Stimulations on Heart Rate Variability of Cancer PatientsStatus: Terminated, Estimated PCD: 2021-09-19
Abstract
Real-world effectiveness and safety of amivantamab for exon 20 EGFR-mutant non-small cell lung cancer (NSCLC) in French early access program: Amexon 20 GFPC.Org: Hospices Civils of Lyon, Hospital Morvan, Hospital Albert Calmette, CHU Saint-Denis La Réunion, Saint-Denis,
Clinical trial
Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress SyndromeStatus: Terminated, Estimated PCD: 2022-03-24
Abstract
Real-life efficacy of nivolumab plus ipilimumab combination in untreated, unresectable malignant pleural mesotheliomas: Result of French early access program—MESOIMMUNE – GFPC 04-2021.Org: HIA SAINTE ANNE, Univ Rouen Normandie, LITIS Lab QuantIF team EA4108, CHU Rouen, Inserm CIC-CRB 1404,
Abstract
Nivolumab (Nivo) plus ipilimumab (Ipi) 6-month treatment versus continuation in patients with advanced non-small-cell-lung cancer (aNSCLC): 3-year results of the IFCT-1701 DICIPLE phase 3 trial.Org: Université Paris Cité, Thoracic Oncology Department & CIC Inserm 1425, Hôpital Bichat Claude Bernard, AP-HP.Nord, Hôpital Bichat Claude Bernard, AP-HP.Nord, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy,